vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and Smith Douglas Homes Corp. (SDHC). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $260.4M, roughly 2.0× Smith Douglas Homes Corp.). Smith Douglas Homes Corp. runs the higher net margin — 1.4% vs -12.3%, a 13.7% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $8.7M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 17.3%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.

GENI vs SDHC — Head-to-Head

Bigger by revenue
GENI
GENI
2.0× larger
GENI
$510.9M
$260.4M
SDHC
Higher net margin
SDHC
SDHC
13.7% more per $
SDHC
1.4%
-12.3%
GENI
More free cash flow
GENI
GENI
$60.8M more FCF
GENI
$69.6M
$8.7M
SDHC
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
17.3%
SDHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENI
GENI
SDHC
SDHC
Revenue
$510.9M
$260.4M
Net Profit
$-63.0M
$3.5M
Gross Margin
25.2%
19.9%
Operating Margin
-11.5%
6.5%
Net Margin
-12.3%
1.4%
Revenue YoY
-9.4%
Net Profit YoY
-14.3%
EPS (diluted)
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
SDHC
SDHC
Q4 25
$510.9M
$260.4M
Q3 25
$335.4M
$262.0M
Q2 25
$215.2M
$223.9M
Q1 25
$119.7M
$224.7M
Q4 24
$413.0M
$287.5M
Q3 24
$285.8M
$277.8M
Q2 24
$184.1M
$220.9M
Q1 24
$97.2M
$189.2M
Net Profit
GENI
GENI
SDHC
SDHC
Q4 25
$-63.0M
$3.5M
Q3 25
$2.1M
Q2 25
$-47.3M
$2.4M
Q1 25
$-25.5M
$2.7M
Q4 24
$-85.5M
$4.1M
Q3 24
$-47.1M
$5.3M
Q2 24
$-35.5M
$3.6M
Q1 24
$-25.2M
$3.0M
Gross Margin
GENI
GENI
SDHC
SDHC
Q4 25
25.2%
19.9%
Q3 25
24.2%
21.0%
Q2 25
19.1%
23.2%
Q1 25
10.7%
23.8%
Q4 24
16.7%
25.5%
Q3 24
20.5%
26.5%
Q2 24
18.6%
26.7%
Q1 24
9.8%
26.1%
Operating Margin
GENI
GENI
SDHC
SDHC
Q4 25
-11.5%
6.5%
Q3 25
-15.3%
6.6%
Q2 25
-21.0%
7.7%
Q1 25
-20.3%
8.7%
Q4 24
-18.0%
10.4%
Q3 24
-13.9%
14.2%
Q2 24
-16.8%
11.7%
Q1 24
-23.7%
11.3%
Net Margin
GENI
GENI
SDHC
SDHC
Q4 25
-12.3%
1.4%
Q3 25
0.8%
Q2 25
-22.0%
1.1%
Q1 25
-21.3%
1.2%
Q4 24
-20.7%
1.4%
Q3 24
-16.5%
1.9%
Q2 24
-19.3%
1.7%
Q1 24
-25.9%
1.6%
EPS (diluted)
GENI
GENI
SDHC
SDHC
Q4 25
$0.39
Q3 25
$0.24
Q2 25
$0.26
Q1 25
$0.30
Q4 24
$0.50
Q3 24
$0.58
Q2 24
$0.40
Q1 24
$0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
SDHC
SDHC
Cash + ST InvestmentsLiquidity on hand
$280.6M
$12.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$724.5M
$86.7M
Total Assets
$1.1B
$557.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
SDHC
SDHC
Q4 25
$280.6M
$12.7M
Q3 25
$110.2M
$14.8M
Q2 25
$110.2M
$16.8M
Q1 25
$110.2M
$12.7M
Q4 24
$100.3M
$22.4M
Q3 24
$100.3M
$23.7M
Q2 24
$100.3M
$17.3M
Q1 24
$100.3M
$32.8M
Stockholders' Equity
GENI
GENI
SDHC
SDHC
Q4 25
$724.5M
$86.7M
Q3 25
$572.4M
$82.2M
Q2 25
$572.4M
$80.0M
Q1 25
$572.4M
$76.9M
Q4 24
$573.0M
$73.6M
Q3 24
$573.0M
$68.4M
Q2 24
$573.0M
$62.1M
Q1 24
$573.0M
$59.7M
Total Assets
GENI
GENI
SDHC
SDHC
Q4 25
$1.1B
$557.6M
Q3 25
$792.3M
$571.6M
Q2 25
$792.3M
$570.2M
Q1 25
$792.3M
$513.9M
Q4 24
$775.7M
$475.9M
Q3 24
$775.7M
$460.1M
Q2 24
$775.7M
$429.3M
Q1 24
$775.7M
$401.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
SDHC
SDHC
Operating Cash FlowLast quarter
$81.9M
$9.8M
Free Cash FlowOCF − Capex
$69.6M
$8.7M
FCF MarginFCF / Revenue
13.6%
3.4%
Capex IntensityCapex / Revenue
2.4%
0.4%
Cash ConversionOCF / Net Profit
2.77×
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$-36.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
SDHC
SDHC
Q4 25
$81.9M
$9.8M
Q3 25
$-4.8M
$22.8M
Q2 25
$-1.2M
$-28.9M
Q1 25
$-14.6M
$-34.9M
Q4 24
$14.9M
$5.5M
Q3 24
$-9.2M
$22.9M
Q2 24
$39.0K
Q1 24
$-9.3M
Free Cash Flow
GENI
GENI
SDHC
SDHC
Q4 25
$69.6M
$8.7M
Q3 25
$-14.2M
$21.4M
Q2 25
$-5.8M
$-31.1M
Q1 25
$-16.0M
$-35.9M
Q4 24
$11.3M
$4.8M
Q3 24
$-11.6M
$22.3M
Q2 24
$-2.1M
Q1 24
$-9.7M
FCF Margin
GENI
GENI
SDHC
SDHC
Q4 25
13.6%
3.4%
Q3 25
-4.2%
8.2%
Q2 25
-2.7%
-13.9%
Q1 25
-13.4%
-16.0%
Q4 24
2.7%
1.7%
Q3 24
-4.1%
8.0%
Q2 24
-1.0%
Q1 24
-5.1%
Capex Intensity
GENI
GENI
SDHC
SDHC
Q4 25
2.4%
0.4%
Q3 25
2.8%
0.5%
Q2 25
2.1%
0.9%
Q1 25
1.2%
0.5%
Q4 24
0.9%
0.2%
Q3 24
0.9%
0.2%
Q2 24
1.0%
Q1 24
0.2%
Cash Conversion
GENI
GENI
SDHC
SDHC
Q4 25
2.77×
Q3 25
10.70×
Q2 25
-12.24×
Q1 25
-13.01×
Q4 24
1.33×
Q3 24
4.28×
Q2 24
0.01×
Q1 24
-3.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

SDHC
SDHC

Southeast$164.7M63%
Central$95.8M37%

Related Comparisons